Bruk Herbst serves as Executive at Zomedica Pharmaceuticals Corp., where they oversee executive responsibilities. Since joining the company, Bruk Herbst has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 29, 2018 involved exercising options for 62,996 shares valued at $138.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 29, 2018 | ZOM | $138.6K | Option Exercise | 62,996 | $2.20 | Discretionary |
Bruk Herbst currently holds 62,996 shares of Zomedica Pharmaceuticals Corp. (ZOM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruk Herbst has been a net neutral trader of ZOM stock. They have purchased $0 and sold $0 worth of shares.
Bruk Herbst's most recent insider trade was on Mar 29, 2018, when they sold 62,996 shares at $2.20 per share.
Get notified when new Form 4 filings are submitted